Hull, United Kingdom

Daniel Blair

This inventor holds 1 USPTO granted patent. Top assignee: University of Illinois. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Blair. Retrieved from https://idiyas.com/inventor/daniel-blair-n4s3trqh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel Blair

Introduction

Daniel Blair is an accomplished inventor based in Hull, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on hinokitiol analogues. His research focuses on developing methods for preparing these analogues and their applications in treating iron-related diseases.

Latest Patents

Daniel Blair holds a patent for "Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof." This patent discloses various analogues of hinokitiol, along with methods for their preparation and pharmaceutical compositions. The invention also outlines methods for utilizing these compounds in the treatment of iron-related diseases.

Career Highlights

Daniel is affiliated with the University of Illinois, where he continues to advance his research and contribute to the academic community. His work has garnered attention for its potential impact on treating specific health conditions.

Collaborations

Daniel has collaborated with notable colleagues, including Martin D. Burke and Anthony S. Grillo. These partnerships have further enriched his research and expanded the scope of his innovations.

Conclusion

Daniel Blair's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work on hinokitiol analogues represents a promising advancement in the treatment of iron-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…